Table 3 Comparison of OCT findings between PAN and DADA2 patients and control group
Parameter | PAN patients (n = 11) Median (min-max) | DADA2 patients (n = 4) Median (min-max) | Control group (n = 15) Median (min-max) | p-value** |
|---|---|---|---|---|
Subfoveal ChT | 342 (201–506) | 374 (298–609) | 242 (194–270) | < 0.0001* |
750 N ChT | 339 (219–471) | 358 (302–628) | 293 (261–307) | 0.049* |
1500 N ChT | 270 (158–458) | 324.5 (285–605) | 341 (324–359) | 0.325 |
750 T ChT | 321 (241–481) | 356.5 (284–581) | 287 (191–305) | 0.007* |
1500 ChT | 391 (217–458) | 317.5 (254–510) | 330 (307–351) | 0.278 |
Total Subfoveal Choroidal Area | 1.28 (0.74–1.86) | 1.2 (1.15–1.56) | 0.83 (0.73–1.15) | 0.007* |
Luminal Area | 0.75 (0.45–1.15) | 0.82 (0.63–0.96) | 0.54 (0.45–0.78) | 0.006* |
Stromal Area | 0.48 (0.25–0.70) | 0.46 (0.33–0.59) | 0.31 (0.24–0.36) | 0.033* |
CVI | 0.62 (0.58–0.71) | 0.64 (0.55–0.71) | 0.64 (0.60–0.71) | 0.910 |